Sustainable biocatalytic synthesis of L-homophenylalanine as pharmaceutical drug precursor

Biotechnology Advances

Volumn 27, Issue 3, 2009, Pages 286-296

  Ahmad, A L ^a   Oh, P C ^a   Abd Shukor, S R ^a  

^a SCHOOL OF CHEMICAL ENGINEERING   (Malaysia)

Author keywords

ACE inhibitor; Biocatalysis; Drug precursor; L homophenylalanine; Membrane bioreactor; Pharmaceuticals

Indexed keywords

ACE INHIBITOR; BIOCATALYSIS; DRUG PRECURSOR; L-HOMOPHENYLALANINE; MEMBRANE BIOREACTOR; PHARMACEUTICALS;

BIOCONVERSION; BIOREACTORS; DRUG PRODUCTS PLANTS; INDUSTRIAL APPLICATIONS; INDUSTRIAL CHEMICALS; SYNTHESIS (CHEMICAL);

DRUG PRODUCTS;

2 AMINO 4 PHENYLBUTYRIC ACID; 2-AMINO-4-PHENYLBUTYRIC ACID; AMINOBUTYRIC ACID DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PRODRUG;

BIOREACTOR; BIOTRANSFORMATION; CATALYSIS; DRUG; MEMBRANE; SUSTAINABILITY;

BIOCATALYSIS; BIOREACTOR; BIOTRANSFORMATION; GREEN CHEMISTRY TECHNOLOGY; METABOLISM; METHODOLOGY; REVIEW; STEREOISOMERISM; SYNTHESIS;

AMINOBUTYRIC ACIDS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOCATALYSIS; BIOREACTORS; BIOTRANSFORMATION; GREEN CHEMISTRY TECHNOLOGY; PRODRUGS; STEREOISOMERISM;

EID: 60849102424     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2009.01.003     Document Type: Review

References (104)

1. Ahmad A.L., Oh P.C., and Abd Shukor S.R. Enhanced biotransformation and removal of biocatalytic compounds in water by membrane bioreactor technology. EuroMed 2008 - Desalination. Dead Sea, Jordan (2008)
2. Ahmad A.L., Oh P.C., Uzir M.H., and Abd Shukor S.R. Biocatalytic synthesis of angiotensin-converting enzyme (ace) inhibitor drug precursors using membrane bioreactor: a review. 6th Regional Symposium on Membrane Science & Technology. Phuket, Thailand (2008)
3. Ahuja S. Chiral Separations: Application and Technology (1997), American Chemical Society
4. Asano Y., Yamada A., Kato Y., Yamaguchi K., Hibino Y., Hirai K., et al. Enantioselective synthesis of (S)-amino acids by phenylalanine dehydrogenase from Bacillus-sphaericus: use of natural and recombinant enzymes. J Org Chem 55 (1990) 5567-5571
5. Belafi-Bako K., Gubicza L., and Mulder M. Integration of Membrane Processes Into Bioconversions (2000), Kluwer Academic/Plenum Publishers, New York
6. Belfort G., and Heath C.A. Enzyme Membrane Reactors. Proceedings of the NATO Advanced Study Institute on Membrane Processes in Separation and Purification (1993), Kluwer Academic Publishers, Curia, Protugal 149-168
7. Blacklock T.J., Shuman R.F., Butcher J.W., Shearin W.E., Budavari J., and Grenda V.J. Synthesis of semisynthetic dipeptides using N-Carboxyanhydrides and Chiral induction on Raney-Nickel: a method practical for large-scale. J Org Chem 53 (1988) 836-844
8. Blaser H.U., Eissen M., Fauquex P.F., Hungerbuehler K., Schmidt E., Sedelmeier G., et al. Comparison of Four Technical Syntheses of Ethyl (R)-2-hydroxy-4-phenylbutyrate (2004), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
9. Bommarius A.S., and Riebel B.R. Biocatalysis: Fundamentals and Applications (2004), Wiley-VCH Verlag GmbH, Weinheim
10. Bommarius A.S., Schwarm M., and Drauz K. Biocatalysis to amino acid-based chiral pharmaceuticals - examples and perspectives. J Mol Catal B Enzym 5 (1998) 1-11
11. Bradshaw C.W., Wong C.H., Hummel W., and Kula M.R. Enzyme-catalyzed asymmetric-synthesis of (s)-2-amino-4-phenylbutanoic acid and (r)-2-hydroxy-4-phenylbutanoic acid. Bioorg Chem 19 (1991) 29-39
12. Buchholz K., Kasche V., and Bornscheuer U.T. Biocatalysts and Enzyme Technology (2005), Wiley-VCH Verlag GmbH, Weinheim
13. Busca P., Paradisi F., Moynihan E., Maguire A.R., and Engel P.C. Enantioselective synthesis of non-natural amino acids using phenylalanine dehydrogenases modified by site-directed mutagenesis. Org Biomol Chem 2 (2004) 2684-2691
14. Chadha A., and Manohar M. Enzymatic resolution of 2-hydroxy-4-phenylbutanoic acid and 2-hydroxy-4-phenylbutenoic acid. Tetrahedron Asymmetry 6 (1995) 651-652
15. Chadha A., Manohar M., Soundararajan T., and Lokeswari T.S. Asymmetric reduction of 2-oxo-4-phenylbutanoic acid ethyl ester by Daucus carota cell cultures. Tetrahedron Asymmetry 7 (1996) 1571-1572
16. Charcosset C. Membrane processes in biotechnology: an overview. Biotechnol Adv 24 (2006) 482-492
17. Chen, S.T., Tseng, M.J., Kao, T., Sookkheo, B., Surat, T., 2000. Facile Synthesis of L-Homophenylalanine By Equilibrium Shift Enzymatic Reaction Using Engineered Tyrosine Aminotransferase. U.S. Patent 6,146,859.
18. Chiang W.D., Tsou M.J., Tsai Z.Y., and Tsai T.C. Angiotensin I-converting enzyme inhibitor derived from soy protein hydrolysate and produced by using membrane reactor. Food Chem 98 (2006) 725-732
19. Cho B.K., Seo J.H., Kang T.W., and Kim B.G. Asymmetric synthesis of L-homophenylalanine by equilibrium-shift using recombinant aromatic L-amino acid transaminase. Biotechnol and Bioeng 83 (2003) 226-234
20. Clark D.S., and Estell D.A. Enzyme Engineering XI. 672 (1992), The New York Academy of Sciences, New York
21. Collins A.N., Sheldrake G.N., and Crosby J. Chirality in Industry II: Developments in the Manufacture and Applications of Optically Active Compounds (1997), John Wiley & Sons, New York
22. Dagenais G.R., Pogue J., Fox K., Simoons M.L., and Yusuf S. Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials. Lancet 368 (2006) 581-588
23. de Lacerda P.S.B., Ribeiro J.B., Leite S.G.F., Coelho R.B., Lima E.L.D., and Antunes O.A.C. Microbial enantioselective reduction of ethyl-2-oxo-4-phenyl-butanoate. Biochem Eng J 28 (2006) 299-302
24. de Lacerda P.S.B., Ribeiro J.B., Leite S.G.F., Ferrara M.A., Coelho R.B., Bon E.P.S., et al. Microbial reduction of ethyl 2-oxo-4-phenylbutyrate. Searching for R-enantioselectivity. New access to the enalapril like ACE inhibitors. Tetrahedron Asymmetry 17 (2006) 1186-1188
25. De Wildeman S.M.A., Sonke T., Schoemaker H.E., and May O. Biocatalytic reductions: from lab curiosity to "first choice". Acc Chem Res 40 (2007) 1260-1266
26. Di Nunno L., Franchini C., Scilimati A., Sinicropi M.S., and Tortorella P. Chemical and chemoenzymatic Routes to 1-(benzothiazol-2-ylsulfanyl)-3-chloropropan-2-ol, a precursor of drugs with potential beta-blocker activity. Tetrahedron Asymmetry 11 (2000) 1571-1583
27. Diez D., Garcia P., Marcos I.S., Basabe P., Garrido N.M., Broughton H.B., et al. Vinylsulfones Versus Alkylsulfones in the Addition to Chiral Imines. Synthesis of N-(tert-butoxycarbonyl)-L-homophenylalanine. Tetrahedron 61 (2005) 11641-11648
28. Doble M., Kruthiventi A.K., and Gaikar V.G. Biotransformations and Bioprocesses (2004), Marcel Dekker, Inc., New York
29. Doig S.D., Boam A.T., Leak D.I., Livingston A.G., and Stuckey D.C. A membrane bioreactor for biotransformations of hydrophobic molecules. Biotechnol Bioeng 58 (1998) 587-594
30. Eguchi T., Iizuka T., Kagotani T., Lee J.H., Urabe I., and Okada H. Covalent linking of poly(ethyleneglycol)-bound NAD with thermus-thermophilus malate-dehydrogenase - NAD(H)-regeneration unit for a coupled 2nd-enzyme reaction. Eur J Biochem 155 (1986) 415-421
31. Erdos E.G. The ACE and I: how ACE inhibitors came to be. FASEB J 20 (2006) 1034-1038
32. Fiechter A. Advances in Biochemical Engineering/Biotechnology (1983), Springer-Verlag, New York
33. Furukawa S., Katayama N., Iizuka T., Urabe I., and Okada H. Preparation of polyethylene glycol-bound Nad and its application in a model enzyme reactor. Febs Lett 121 (1980) 239-242
34. Giri A., Dhingra V., Giri C.C., Singh A., Ward O.P., and Narasu M.L. Biotransformations using plant cells, organ cultures and enzyme systems: current trends and future prospects. Biotechnol Adv 19 (2001) 175-199
35. Hanson, R., Donovan, M.J., Goldberg, S., Jass, P.A., Li, W.S., Patel, R., et al., 2000. Stereoselective Reductive Amination of Ketones. Patent US 6,140,088.
36. Hayashi K., Nunami K., Kato J., Yoneda N., Kubo M., Ochiai T., et al. Studies on angiotensin converting enzyme-inhibitors.4. Synthesis and angiotensin converting enzyme inhibitory activities of 3-acyl-1-alkyl-2-oxoimidazolidine-4-carboxylic acid-derivatives. J Med Chem 32 (1989) 289-297
37. Herold P., Indolese A.F., Studer M., Jalett H.P., Siegrist U., and Blaser H.U. New technical synthesis of ethyl (R)-2-hydroxy-4-phenylbutyrate of high enantiomeric purity. Tetrahedron 56 (2000) 6497-6499
38. Hillier M.C., and Reider P.J. Stereoselective synthesis from a process research perspective. Drug Discov Today 7 (2002) 303-314
39. Hsu S.K., Lo H.H., Kao C.H., Lee D.S., and Hsu W.H. Enantioselective synthesis of L-homophenylalanine by whole cells of recombinant Escherichia coli expressing L-aminoacylase and N-acylamino acid racemase genes from Deinococcus radiodurans BCRC12827. Biotechnol Prog 22 (2006) 1578-1584
40. Hsu S.K., Lo H.H., Lin W.D., Chen I.C., Kao C.H., and Hsu W.H. Stereoselective synthesis of l-homophenylalanine using the carbamoylase method with in situ racemization via N-acylamino acid racemase. Process Biochem 42 (2007) 856-862
41. Hummel W., Schutte H., Schmidt E., Wandrey C., and Kula M.R. Isolation of L-phenylalanine dehydrogenase from rhodococcus Sp M4 and its application for the production of L-phenylalanine. Appl Microbiol Biotechnol 26 (1987) 409-416
42. Iwasaki G., Kimura R., Numao N., and Kondo K. A practical and diastereoselective synthesis of angiotensin converting enzyme-inhibitors. Chem Pharm Bull 37 (1989) 280-283
43. Johnson A.L., Price W.A., Wong P.C., Vavala R.F., and Stump J.M. Synthesis and pharmacology of the potent angiotensin-converting enzyme-inhibitor N-[1(S)-(ethoxycarbonyl)-3-phenylprophyl]-(S)-alanyl-(S)-pyroglutamic acid. J Med Chem 28 (1985) 1596-1602
44. Kao C.H., Lo H.H., Hsu S.K., and Hsu W.H. A novel hydantoinase process using recombinant Escherichia Coli cells with dihydropyrimidinase, and L-N-carbamoylase activities as biocatalyst for the production of L-homophenylalanine. J Biotechnol 134 (2008) 231-239
45. Katayama N., Hayakawa K., Urabe I., and Okada H. Kinetic-properties of N-6-(2-Carboxyethyl)-NAD(H) and poly(ethylene glycol)-bound NAD(H) for alcohol, lactate, malate and glyceraldehyde-3-phosphate dehydrogenase from different organisms. Enzyme Microb Technol 6 (1984) 538-542
46. Katayama N., Urabe I., and Okada H. Steady-state kinetics of coupled two-enzyme reactor with recycling of poly(ethylene glycol)-bound NAD. Eur J Biochem 132 (1983) 403-409
47. Kishimoto T., Itami M., Yomo T., Urabe I., Yamada Y., and Okada H. Improved methods for the preparation of N6-(2-carboxyethyl)-Nad and poly(ethylene glycol)-bound Nad(H). J Ferment Bioeng 71 (1991) 447-449
48. Kragl U., Kruse W., Hummel W., and Wandrey C. Enzyme engineering aspects of biocatalysis: cofactor regeneration as example. Biotechnol Bioeng 52 (1996) 309-319
49. Krix G., Bommarius A.S., Drauz K., Kottenhahn M., Schwarm M., and Kula M.R. Enzymatic reduction of alpha-keto acids leading to L-amino acids, D- or L-hydroxy acids. J Biotechnol 53 (1997) 29-39
50. Larissegger-Schnell B., Glueck S.M., Kroutil W., and Faber K. Enantio-complementary deracemization of (+/-)-2-hydroxy-4-phenylbutanoic acid and (+/-)-3-phenyllactic acid using lipase-catalyzed kinetic resolution combined with biocatalytic racemization. Tetrahedron 62 (2006) 2912-2916
51. Li T., Kootstra A.B., and Fotheringham I.G. Nonproteinogenic alpha-amino acid preparation using equilibrium shifted transamination. Org Process Res Dev 6 (2002) 533-538
52. Li X.S., Yeung C.H., Chan A.S.C., Lee D.S., and Yang T.K. An efficient synthesis of chiral homophenylalanine derivatives via enantioselective hydrogenation. Tetrahedron Assymmetry 10 (1999) 3863-3867
53. Liese A., Kragl U., Kierkels H., and Schulze B. Membrane reactor development for the kinetic resolution of ethyl 2-hydroxy-4-phenylbutyrate. Enzyme Microb Technol 30 (2002) 673-681
54. Liese A., Seelbach K., and Wandrey C. Industrial Biotransformations (2000), Wiley-VCH Verlag GmbH, Weinheim
55. Liese A., and Villela M. Production of fine chemicals using biocatalysis. Curr Opin Biotechnol 10 (1999) 595-603
56. Lin S.S., Harada T., Hata C., Miyawaki O., and Nakamura K. Nanofiltration membrane bioreactor for continuous asymmetric reduction of 2-ketoglutarate to produce L-glutamate with NADH regeneration. J Ferment Bioeng 83 (1997) 54-58
57. Liu W.F., and Wang P. Cofactor regeneration for sustainable enzymatic biosynthesis. Biotechnol Adv 25 (2007) 369-384
58. Lo H.H., Hsu S.K., Lin W.D., Chan N.L., and Hsu W.H. Asymmetrical synthesis of L-homophenylalanine using engineered Escherichia coli aspartate aminotransferase. Biotechnol Prog 21 (2005) 411-415
59. Lo H.H., Kao C.H., Lee D.S., Yang T.K., and Hsu W.H. Enantioselective synthesis of (S)-2-amino-4-phenylbutanoic acid by the hydantoinase method. Chirality 15 (2003) 699-702
60. Lye G.J., and Woodley J.M. Application of in situ product-removal techniques to biocatalytic processes. Trends Biotechnol 17 (1999) 395-402
61. Mak K.K.W., Wollenberger U., Scheller F.W., and Renneberg R. An amperometric bi-enzyme sensor for determination of formate using cofactor regeneration. Biosens Bioelectron 18 (2003) 1095-1100
62. Mansson M.O., and Larsson P.O. Covalent enzyme-coenzyme complexes of liver alcohol dehydrogenase and NAD. Methods Enzymol 46 (1982) 205-278
63. Marcano J.G.S., and Tsotsis T.T. Catalytic Membranes and Membrane Reactors (2002), Wiley-VCH Verlag GmbH, Weinheim
64. McMurray J., Cohen-Solal A., Dietz R., Eichhorn E., Erhardt L., Hobbs F.D.R., et al. Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice. Eur J Heart Fail 7 (2005) 710-721
65. Mishra R., Jain S.R., and Kumar A. Microbial production of dihydroxyacetone. Biotechnol Adv 26 (2008) 293-303
66. Nagasawa T., and Yamada H. Interrelations of chemistry and biotechnology. 6. Microbial-production of commodity chemicals. Pure Appl Chem 67 (1995) 1241-1256
67. Nakamura A., Urabe I., and Okada H. Anchimeric assistance in the intramolecular reaction of glucose-dehydrogenase-polyethylene glycol Nad conjugate. J Biol Chem 261 (1986) 6792-6794
68. Ondetti M.A., and Cushman D.W. Inhibition of the renin-angiotensin system: a new approach to the therapy of hypertension. J Med Chem 24 (1981) 355-361
69. Patel R.N. Stereoselective Biocatalysis (2000), Marcel Dekker, Inc., New York
70. Patel R.N. Biocatalytic synthesis of chiral pharmaceutical intermediates. Food Technol Biotechnol 42 (2004) 305-325
71. Patel R.N., Goswami A., Chu L., Donovan M.J., Nanduri V., Goldberg S., et al. Enantioselective microbial reduction of substituted acetophenones. Tetrahedron Asymmetry 15 (2004) 1247-1258
72. Politino M., Cadin M.M., Skonezny P.M., and Chen J.G. Process for Preparing Dipeptidyl IV Inhibitors and Intermediates Therefor (2005) WO 2005/106011 A3
73. Pollard D.J., and Woodley J.M. Biocatalysis for pharmaceutical intermediates: the future is now. Trends Biotechnol 25 (2007) 66-73
74. Rasor J.P., and Voss E. Enzyme-catalyzed processes in pharmaceutical industry. Appl Catal A Gen 221 (2001) 145-158
75. Regla I., Luna H., Perez H.I., Demare P., Bustos-Jaimes I., Zaldivar V., et al. Enzymatic Resolution of N-acetyl-homophenylalanine with mammalian kidney acetone powders. Tetrahedron Asymmetry 15 (2004) 1285-1288
76. Ribeiro J.B., Ramos M.D., Neto F.R., Leite S.G.F., and Antunes O.A.C. New microbiological catalytic accesses to (S)-fluoxetine. Catal Commun 6 (2005) 131-133
77. Ribeiro J.B., Ramos M.D., Neto F.R.D., Leite S.G.F., and Antunes O.A.C. Microbiological enantioselective reduction of ethyl acetoacetate. J Mol Catal B Enzym 24-5 (2003) 121-124
78. Riva S., Carrea G., Veronese F.M., and Buckmann A.F. Effect of coupling site and nature of the polymer on the coenzymatic properties of water-soluble macromolecular NAD derivatives with selected dehydrogenase enzymes. Enzyme Microb Technol 8 (1986) 556-560
79. Roberts S.M. Preparative biotransformations: the employment of enzymes and whole-cells in synthetic organic chemistry. J Chem Soc Perkin Trans 1 (1998) 157-169
80. Schmidt E., Ghisalba O., Gygax D., and Sedelmeier G. Optimization of a process for the production of (R)-2-hydroxy-4-phenylbutyric acid: an intermediate for inhibitors of angiotensin converting enzyme. J Biotechnol 24 (1992) 315-327
81. Seelbach K., and Kragl U. Nanofiltration membranes for cofactor retention in continuous enzymatic synthesis. Enzyme Microb Technol 20 (1997) 389-392
82. Senuma M., Nakamichi K., Nabe K., Nishimoto S., and Tosa T. Industrial-production of L-2-amino-4-phenylbutyric acid from 2-oxo-4-phenylbutyric acid by Paracoccus Denitrificans containing aminotransferase activity. Appl Biochem Biotechnol 22 (1989) 141-150
83. Servi S., Tessaro D., and Pedrocchi-Fantoni G. Chemo-enzymatic deracemization methods for the preparation of enantiopure non-natural alpha-amino acids. Coord Chem Rev 252 (2008) 715-726
84. Seymour A.A., Swerdel J.N., and Abboaoffei B. Antihypertensive activity during inhibition of neutral endopeptidase and angiotensin converting enzyme. J Cardiovasc Pharmacol 17 (1991) 456-465
85. Shaked Z., and Whitesides G.M. Enzyme-catalyzed organic-synthesis - NADH regeneration by using formate dehydrogenase. J Am Chem Soc 102 (1980) 7104-7105
86. Sheldon R.A. Chirotechnology - Industrial Synthesis of Optically Active Compounds (1993), Marcel Dekker, Inc., New York
87. Skeggs L.T., Dorer F.E., Kahn J.R., Lentz K.E., and Levin M. Experimental Renal Hypertension: The Discovery of the Renin-Angiotensin System (1981), John Wiley & Sons, Inc., Hoboken
88. Smith J.E. Biotechnology (2004), Cambridge University Press, United Kingdom
89. Straathof A.J.J., Panke S., and Schmid A. The production of fine chemicals by biotransformations. Curr Opin Biotechnol 13 (2002) 548-556
90. Syldatk C., Laufer A., Muller R., and Hoke H. Production of optically pure D- and L-amino acids by bioconversion of D,L-5-monosubstituted hydantoin derivatives. Adv Biochem Eng Biotechnol 41 (1990) 29-75
91. Taylor P.P., Pantaleone D.P., Senkpeil R.F., and Fotheringham I.G. Novel biosynthetic approaches to the production of unnatural amino acids using transaminases. Trends Biotechnol 16 (1998) 412-418
92. Trevor A.J., Katzung B.G., and Masters S.B. Katzung & Trevor's Pharmacology (2002), McGraw-Hill Companies, Inc., New York
93. Vanhommerig S.A.M., Sluyterman L.A.A.E., and Meijer E.M. Kinetic and modelling studies of NAD(+) and poly(ethylene glycol)-bound NAD(+) in horse liver alcohol dehydrogenase. Biochim Biophys Acta Prot Struct Mol Enzymol 1295 (1996) 125-138
94. Wang Y.F., Chen S.T., Liu K.K.C., and Wong C.H. Lipase-catalyzed irreversible trans-esterification using enol esters: resolution of cyanohydrins and syntheses of ethyl (R)-2-hydroxy-4-phenylbutyrate and (S)-propranolol. Tetrahedron Lett 30 (1989) 1917-1920
95. Wichmann R., Wandrey C., Buckmann A.F., and Kula M.R. Continuous enzymatic transformation in an enzyme membrane reactor with simultaneous NAD(H) regeneration (reprinted from Biotechnology and Bioengineering, 1981; 23, 2789-2802). Biotechnol Bioeng 67 (2000) 791-804
96. Williams R.M., Sinclair P.J., Zhai D., and Chen D. Practical asymmetric syntheses of alpha-amino-acids through carbon carbon bond constructions on electrophilic glycine templates. J Am Chem Soc 110 (1988) 1547-1557
97. Wong C.H., Drueckhammer D.G., and Sweers H.M. enzymatic vs fermentative synthesis: thermostable glucose-dehydrogenase catalyzed regeneration of NAD(P)H for use in enzymatic-synthesis. J Am Chem Soc 107 (1985) 4028-4031
98. Wyvratt M.J. Evolution of angiotensin-converting enzyme inhibitors. Clin Physiol Biochem 6 (1988) 217-229
99. Xiao X.F., Luo X.B., Chen B., and Yao S.Z. Determination of angiotensin converting enzyme inhibitory activity by high-performance liquid chromatography/electrospray-mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 834 (2006) 48-54
100. Xie Y.N., Lou R.L., Li Z., Mi A.Q., and Jiang Y.H. DPAMPP in catalytic asymmetric reactions: enantioselective synthesis of L-homophenylalanine. Tetrahedron Asymmetry 11 (2000) 1487-1494
101. Xu Q.Y., Wang G.X., Wang X.C., Wu T.X., Pan X.F., Chan A.S.C., et al. The synthesis of L-(+)-homophenylalanine hydrochloride. Tetrahedron Asymmetry 11 (2000) 2309-2314
102. Zawalich M.E., and Fisher R.J. In-Situ Regeneration of Co-Enzyme NADH with an Electro-Enzymatic Biomimetic Membranes (1998), IEEE
103. Zhao H., Luo R.G., and Malhotra S.V. Kinetic study on the enzymatic resolution of homophenylalanine ester using ionic liquids. Biotechnol Prog 19 (2003) 1016-1018
104. Zhao H., Luo R.G., Wei D., and Malhotra S.V. Concise synthesis and enzymatic resolution of L-(+)-homophenylalanine hydrochloride. Enantiomer 7 (2002) 1-3